Heparan sulfate proteoglycans (HSPGs), including syndecans, glypicans, and perlecan, further contribute to chemoresistance by regulating growth factor bioavailability, cell–ECM adhesion, and drug penetration within the tumor microenvironment. The gene discussed is CD44; the disease is neoplasm.